Children’s Poster Contest on Healthy Eating

Objective: To encourage children in 3rd, 4th, and 5th grades to learn about good nutrition and display their knowledge in an attractive poster. Method: A children’s poster contest was conducted through schools in the Washington, DC metro area in conjunction with the 2004 National Health Education Week’s campaign, “Healthy Eating – Every Bite Counts!”. Posters were judged on a 100 point scale, and six winners were chosen for each grade level. The children with the winning posters received cash prizes and were honored at an awards ceremony at the Society for Public Health Education’s (SOPHE) annual meeting. Results: Eligible entries were received from 76 students at 14 schools in the Arlington, VA and Washington, DC school districts. Almost all of the posters showed a good knowledge of nutrition by the students. Conclusion: National Health Education Week themes that are specific to children should encourage participation among schools, teachers, and parents. Partnerships offer possibilities for dissemination of public health education campaigns. A children’s poster contest about healthy eating in schools in the Washington, DC area was successful in gaining 76 entries from 14 schools, and children displayed a high level of knowledge of which foods were healthy for them and a high level of creativity and artistic talent

On Observational Predictions from Multidimensional Gravity

We discuss possible observational manifestations of static, spherically symmetric solutions of a class of multidimensional theories of gravity, which includes the low energy limits of supergravities and superstring theories as special cases. We discuss the choice of a physical conformal frame to be used for the description of observations. General expressions are given for (i) the Eddington parameters $\beta$ and $\gamma$, characterizing the post-Newtonian gravitational field of a central body, (ii) p-brane black hole temperatures in different conformal frames and (iii) the Coulomb law modified by extra dimensions. It is concluded, in particular, that $\beta$ and $\gamma$ depend on the integration constants and can be therefore different for different central bodies. If, however, the Einstein frame is adopted for describing observations, we always obtain $\gamma=1$. The modified Coulomb law is shown to be independent of the choice of a 4-dimensional conformal frame. We also argue the possible existence of specific multidimensional objects, T-holes, potentially observable as bodies with mirror surfaces.Comment: 16 pages, Latex2

Evolution of the Scale Factor with a Variable Cosmological Term

Evolution of the scale factor a(t) in Friedmann models (those with zero pressure and a constant cosmological term Lambda) is well understood, and elegantly summarized in the review of Felten and Isaacman [Rev. Mod. Phys. 58, 689 (1986)]. Developments in particle physics and inflationary theory, however, increasingly indicate that Lambda ought to be treated as a dynamical quantity. We revisit the evolution of the scale factor with a variable Lambda-term, and also generalize the treatment to include nonzero pressure. New solutions are obtained and evaluated using a variety of observational criteria. Existing arguments for the inevitability of a big bang (ie., an initial state with a=0) are substantially weakened, and can be evaded in some cases with Lambda_0 (the present value of Lambda) well below current experimental limits.Comment: 29 pages, 12 figures (not included), LaTeX, uses Phys Rev D style files (revtex.cls, revtex.sty, aps.sty, aps10.sty, prabib.sty). To appear in Phys Rev

Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule

Background: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. Methods: We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis. Results: There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P = 0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy. Conclusions: This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US

Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

Precise subtype diagnosis of non–small cell lung carcinoma is increasingly relevant, based on the availability of subtype-specific therapies, such as bevacizumab and pemetrexed, and based on the subtype-specific prevalence of activating epidermal growth factor receptor mutations

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication

Global parasite and Rattus rodent invasions: The consequences for rodent-borne diseases

We summarize the current knowledge on parasitism-related invasion processes of the globally invasive Rattus lineages, originating from Asia, and how these invasions have impacted the local epidemiology of rodent-borne diseases. Parasites play an important role in the invasion processes and successes of their hosts through multiple biological mechanisms such as "parasite release", "immunocompetence advantage", “biotic resistance” and "novel weapon". Parasites may also greatly increase the impact of invasions by spillover of parasites and other pathogens, introduced with invasive hosts, into new hosts potentially leading to novel emerging diseases. Another potential impact is the ability of the invader to amplify local parasites by spill-back. In both cases, local fauna and humans may be exposed to new health risks, which may decrease biodiversity and may potentially cause increases in human morbidity and mortality. Here we review the current knowledge on these processes and propose some research priorities